Skip to main content
SpringerLink
Log in

Options and Problems of Drug Application in Patients with Advanced Cancer

  • Chapter
Palliative Care in Oncology

  • 1713 Accesses

Abstract

Pharmacokinetics describes the movement of a drug through the body. The pharmacokinetic properties of a drug are described by the time-dependent processes liberation, absorption, distribution, metabolism, and elimination (“LADME”; Table 10.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aronoff GR, Bennett WM, Burns JS (2007) Anagesics and Sedatives, hypnotics, and other drugs used in psychiatry. In: A.C.o. Physicians (ed) Drug prescribing in renal failure, 5th edn. American College of Physicians, Philadelphia

    Google Scholar 

  • Ashley C, Currie A (2009) The renal drug handbook, 3rd edn. Radcliffe Publishing Ltd., Oxford

    Google Scholar 

  • Brater DC (2009) Drug dosing in patients with impaired renal function. Clin Pharmacol Ther 86(5):483–489

    Article  CAS  PubMed  Google Scholar 

  • Caraceni A et al (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13(2):e58–e68

    Article  CAS  PubMed  Google Scholar 

  • Chopra V et al (2012) Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med 125(8):733–741

    Article  PubMed  Google Scholar 

  • Davies A et al (2011) Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 15(7):756–763

    Article  PubMed  Google Scholar 

  • Delco F et al (2005) Dose adjustment in patients with liver disease. Drug Saf 28(6):529–545

    Article  CAS  PubMed  Google Scholar 

  • Dickman A, Littlewood C, Varga J (2011) The syringe driver: continuous subcutaneous infusions. In: Palliative care, 3rd edn. Oxford University Press, Oxford

    Google Scholar 

  • Drayer DE (1976) Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. Clin Pharmacokinet 1(6):426–443

    Article  CAS  PubMed  Google Scholar 

  • Fleisher D et al (1999) Drug, meal and formulation interactions influencing drug absorption after oral administration: clinical implications. Clin Pharmacokinet 36(3):233–254

    Article  CAS  PubMed  Google Scholar 

  • Fonzo-Christe C et al (2005) Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review. Palliat Med 19:208–219

    Article  PubMed  Google Scholar 

  • Garrett E.R. (1994) The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination. J Pharmacokinet Biopharm 22(2):103–128

    Google Scholar 

  • Gilbar PJ (1999) A guide to enternal drug administration in palliative care. J Pain Symptom Manage 17(3):197–207

    Article  CAS  PubMed  Google Scholar 

  • Hafner K (2013) Off-Label-Use von Arzneimitteln in der Palliativmedizin. In: Mathematisch-Naturwissenschaftlichen Fakultät. Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, p 270

    Google Scholar 

  • Hansen S et al (2009) National influences on catheter-associated bloodstream infection rates: practices among national surveillance networks participating in the European HELICS project. J Hosp Infect 71(1):66–73

    Article  CAS  PubMed  Google Scholar 

  • Herndon CM, Fike DS (2001) Continuous subcutaneous infusion practices of United States hospices. J Pain Symptom Manage 22(6):1027–1034

    Article  CAS  PubMed  Google Scholar 

  • Hockenhull JC et al (2008) The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess 12(12):154

    Article  Google Scholar 

  • I.E. Commission (ed) (2012) IEC 60601-2-24 EN-medical electrical equipment – part 2–24: particular requirements for the safety of infusion pumps and controllers, 1st edn. IEC, Geneva

    Google Scholar 

  • Infusionzubereitungen in Europäisches Arzneibuch 7.0 Ausgabe Grundwerk, Band 1 (2011) p 1100

    Google Scholar 

  • Jauch KW et al (2007) 9 Technik und Probleme der Zugänge in der parenteralen Ernährung. Aktuel Ernahrungsmed 32(S 1):S41–S53

    Article  Google Scholar 

  • Kamath PS et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33(2):464–470

    Article  CAS  PubMed  Google Scholar 

  • Menahem S, Shvartzman P (2010) Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump? Support Care Cancer 18(9):1165–1170

    Article  PubMed  Google Scholar 

  • Mermel LA et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mitten T (2001) Subcutaneous drug infusions: a review of problems and solutions. Int J Palliat Nurs 7(2):75–85

    Article  CAS  PubMed  Google Scholar 

  • Morgan S, Evans N (2004) A small observational study of the longevity of syringe driver sites in palliative care. Int J Palliat Nurs 10(8):405–412

    Article  PubMed  Google Scholar 

  • NPSA (National Patient Safety Agency) (2010) Safer ambulatory syringe drivers. In: Rapid response report RRR019. Available from: www.npsa.uk

  • O’Doherty CA et al (2001) Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire. Palliat Med 15(2):149–154

    Article  PubMed  Google Scholar 

  • O’Grady NP et al (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52(9):e162–e193

    Google Scholar 

  • Parenteralia 5.2/0520 (2012) Arzneibuchkommentar Gesamtwerk einschliesslich 43. Aktualisierungslieferung, Wissenschaftliche Verlagsgesellschaft Stuttgart, Govi-Verlag GmbH, Stuttgart, Eschborn

    Google Scholar 

  • Pugh RN et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649

    Article  CAS  PubMed  Google Scholar 

  • Radbruch L et al (2011) Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: an EPCRC opioid guidelines project. Palliat Med 25(5):578–596

    Article  PubMed  Google Scholar 

  • Rhee C, Broadbent AM (2007) Palliation and liver failure: palliative medications dosage guidelines. J Palliat Med 10:677–685

    Article  PubMed  Google Scholar 

  • RKI (2002), Prävention Gefäßkatheterassoziierter Infektionen - Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI). Bundesgesundheitsblatt 45:907–924

    Google Scholar 

  • Rose M, Currow DC (2009) The need for chemical compatibility studies of subcutaneous medication combinations used in palliative care. J Pain Palliat Care Pharmacother 23(3):223–230

    Article  PubMed  Google Scholar 

  • S.o.H.P.o. Australia (2011) Australian don’t rush to crush handbook, 1st edn. SHPA, Collingwood

    Google Scholar 

  • Schiffer CA et al (2013) Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(10):1357–1370

    Article  PubMed  Google Scholar 

  • Schlatter C (2008) Dosisanpassung bei Leberinsuffizienz. PZ Prisma 15(4):213–224

    CAS  Google Scholar 

  • Schlatter C et al (2009) Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation. Drug Saf 32(7):561–578

    Article  CAS  PubMed  Google Scholar 

  • Schneider JJ, Wilson KM, Ravenscroft PJ (1997) A study of the osmolality and pH of subcutaneous drug infusion solutions. Aust J Hosp Pharm 27:29–31

    CAS  Google Scholar 

  • Simon ST et al (2012) Acceptability and preferences of six different routes of drug application for acute breathlessness: a comparison study between the United Kingdom and Germany. J Palliat Med 15(12):1374–1381

    Article  PubMed Central  PubMed  Google Scholar 

  • Sloss A (2009) Prescribing in liver disease. Aust Prescriber 32:32–35

    Google Scholar 

  • Tegeder I, Geisslinger G, Lotsch J (1999) Therapy with opioids in liver or renal failure. Schmerz 13(3):183–95

    Article  CAS  PubMed  Google Scholar 

  • Twycross R, Wilcock A (eds) (2012) Palliative care formulary (PCF 4), 4th edn. Nottingham: palliativedrugs.com

    Google Scholar 

  • Wilcock A et al (2006) Drugs given by a syringe driver: a prospective multicentre survey of palliative care services in the UK. Palliat Med 20(7):661–664

    Article  PubMed  Google Scholar 

  • Williams NT (2008) Medication administration through enteral feeding tubes. Am J Health Syst Pharm 65(24):2347–2357

    Article  CAS  PubMed  Google Scholar 

  • Yamada R et al (2010) Patient-reported usefulness of peripherally inserted central venous catheters in terminally Ill cancer patients. J Pain Symptom Manage 40(1):60–66

    Article  PubMed  Google Scholar 

  • Zhu LL, Zhou Q (2013) Therapeutic concerns when oral medications are administered nasogastrically. J Clin Pharm Ther 38(4):272–276

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Palliative Medicine, University of Munich, Munich, Germany

    Constanze Rémi MSc & Claudia Bausewein MD, PhD, MSc

Authors
  1. Constanze Rémi MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Bausewein MD, PhD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Constanze Rémi MSc .

Editor information

Editors and Affiliations

  1. Department of Palliative Medicine, University Medical Center, Göttingen, Germany

    Bernd Alt-Epping

  2. Department of Palliative Medicine, University Medical Center, Göttingen, Germany

    Friedemann Nauck

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rémi, C., Bausewein, C. (2015). Options and Problems of Drug Application in Patients with Advanced Cancer. In: Alt-Epping, B., Nauck, F. (eds) Palliative Care in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46202-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46202-7_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46201-0

  • Online ISBN: 978-3-662-46202-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation